| Nov 15 |
Q3 2024 Mink Therapeutics Inc Earnings Call
|
| Nov 15 |
MiNK Therapeutics Inc (INKT) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
| Nov 14 |
MiNK Therapeutics, Inc. (INKT) Q3 2024 Earnings Conference Call Transcript
|
| Nov 14 |
MiNK Therapeutics GAAP EPS of -$0.05
|
| Nov 14 |
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
|
| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 11 |
MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report
|
| Nov 7 |
MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024
|
| Oct 31 |
MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors
|
| Oct 9 |
MiNK Therapeutics Inc (INKT) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
